[Thrombophilias and peripheral arterial occlusive disease].
Peripheral arterial occlusive disease is a frequent disease due to the classical vascular risk factors such as smoking, diabetes mellitus, dyslipidemia, and hypertension. Despite these risk factors, many thrombophilias (physiological inhibitors defects, Factor V Leiden and 20210A prothrombin gene variant, antiphospholipid antibodies, mild hyperhomocysteinemia 15-30micromol/l) can be evoked in some clinical forms of peripheral arterial occlusive disease. This paper provides a synthesis of the published data about this topic. Screening for these thrombophilias is justified in patients with venous thromboembolic disease, or signs of antiphospholipid syndrome and possibly in different situations such as premature atheroma of lower limbs, chronic ischaemia, evolutive disease despite adapted treatment and revascularisation failures without evident technical explanation. Except for the antiphospholipid syndrome, there is currently no consensus for systematic screening of thrombophilia and treatment in patients with peripheral arterial occlusive disease.
Le Hello
C
C
Médecine vasculaire, CHU de Caen, 14033 Caen cedex 9, France. lehello-c@chu-caen.fr
Blacher
J
J
Conard
J
J
Piette
J-C
JC
Constans
J
J
D000328:Adult; D000991:Antithrombins / Q000627:therapeutic use; D001157:Arterial Occlusive Diseases / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology*; D005165:Factor V / Q000235:genetics; D005602:France / Q000453:epidemiology; D014644:Genetic Variation; D006801:Humans; D008403:Mass Screening; D008875:Middle Aged; D016491:Peripheral Vascular Diseases / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology*; D015995:Prevalence; D011516:Prothrombin / Q000235:genetics; D012307:Risk Factors; D019851:Thrombophilia / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics / Q000503:physiopathology*; D055815:Young Adult
D000991:Antithrombins; C095381:factor V Leiden; D005165:Factor V; D011516:Prothrombin